Navigation Links
The nude mouse tale: Omega-3 fats save the life of a terminal cancer patient

Ron Pardini is not a medical doctor. Yet he is seen as a hero by his cancer-stricken neighbor, "D.H." Pardini helped the 78-year-old after D.H. was diagnosed with terminal lung cancer.

"In 2000 he was told by his doctor he had only a few months to live," said Pardini, a professor of biochemistry and associate director of the Nevada Agricultural Experiment Station at the University of Nevada, Reno. "But five years later, he is still alive, and has even gained a little weight."

The cancerous tumors found in D.H.'s lungs have shrunk to 10 percent of what they were in 2000, according to last year's computed tomography (CT) scans.

What worked with DH is not a common medical treatment such as chemotherapy or surgical excision. It was a nutritional intervention, drastically increasing the patient's intake of omega-3 fatty acids, which are often found in fish oil or golden algae oil.

Pardini's previous research showed that omega-3 fatty acids significantly depressed the growth of human mammary, ovarian, colon, prostate and pancreatic cancer cells that were injected into athymic mice--also known as nude mice.

His studies also demonstrated that fish oil consumption improves a mouse's responsiveness to chemotherapy.

Fish oil research was inspired by observations that Inuit Eskimo populations have less breast and prostate cancer deaths. So far, though, most studies in this country are limited to animal models, but a case study about D.H., which was published in the recent issue of the Nutrition and Cancer journal, could be a major step forward for human clinical trials.

While beginning to take high dose of fish oil and golden algae oil capsules daily, D.H. also reduced corn-based foods from his diet. Corn contains omega-6 fatty acids that Pardini said are found to increase cancer growth.

Pardini is optimistic of what his findings may contribute to cancer treatment.

"We have good evidence for employing nutritional interventions to improve cancer treatment and patient well-being," he said.

Pardini wants to be able to provide viable non-toxic, over-the-counter solutions for the numerous people with fear of cancer in the back of their minds. The Nutrition and Cancer article is co-authored by Nevada nutrition Professor David Wilson and University of Nevada medical school Professors Steven Schiff, Stephen Bajo and Randall Pierce.


'"/>

Source:University of Nevada College of Agriculture, Biotechnology, and Natural Resources


Related biology news :

1. Man and mouse share genome structures
2. Genome-wide mouse study yields link to human leukemia
3. Report that delayed motherhood decreases life expectancy of mouse offspring
4. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
5. Stem cells in bone marrow replenish mouse ovaries
6. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
7. Researchers extend mouse lifespan by protecting against free radicals
8. Gene therapy advance treats hemophilia in mouse models
9. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
10. New technique could alter field of mouse genetics
11. Building a better mouse model of lung cancer: FHIT counts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... India , December 1, 2016 ... Authentication type (Fingerprint, Voice), Future Technology (Iris Recognition ... and Region - Global Forecast to 2021", published ... USD 442.7 Million in 2016, and is projected ... at a CAGR of 14.06%.      ...
(Date:11/30/2016)... 2016 Not many of us realize that we spend ? of our ... need to do it well. Inadequate sleep levels have been found to lead to ... and even cancer. Maybe now is the best time to rethink how ... to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dan Kephart as its chief science officer ... assume his responsibilities at Neogen effective Jan. 1. ... for the agribusiness unit of Thermo Fisher Scientific, as ... Life Technologies. His extensive industry experience also includes the ...
(Date:12/7/2016)... 2016  Nordion, a standalone business of Sterigenics ... today,s award by the United States Department of ... the Phase II cooperative agreement funding to GA ... University of Missouri Research Reactor Center (MURR ® ... establishment of a new, reliable supply of molybdenum ...
(Date:12/7/2016)... , Dec. 7, 2016  Vyriad Inc. announced ... to the company,s Board of Directors. "We ... we build our business and develop our oncolytic viruses ... therapy," said Stephen Russell , MD, PhD, CEO ... , share our vision and passion for making a ...
Breaking Biology Technology: